2BHL - JenaLib

Biol.Unit 1 - manually (Jmol Viewer)

Asym.Unit - manually (Jmol Viewer)

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Title :   X-RAY STRUCTURE OF HUMAN GLUCOSE-6-PHOSPHATE DEHYDROGENASE (DELETION VARIANT) COMPLEXED WITH GLUCOSE-6-PHOSPHATE

Authors :   M. Kotaka, S. Gover, V. M. S. Lam, M. J. Adams

Date :   13 Jan 05 (Deposition) - 25 Apr 05 (Release) - 05 Feb 14 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.90

Chains :   Asym. Unit : A,B
Biol. Unit 1: A,B  (2x)

Keywords :   Oxidoreductase, Oxidoreductase (Choh(D)-Nadp), Glucose Metabolism (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   M. Kotaka, S. Gover, L. Vandeputte-Rutten, S. W. N. Au, V. M. S. Lam, M. J. Adams
Structural Studies Of Glucose-6-Phosphate And Nadp+ Binding To Human Glucose-6-Phosphate Dehydrogenase
Acta Crystallogr. , Sect. D V. 61 495 2005
PubMed-ID: 15858258 | Reference-DOI: 10.1107/S0907444905002350
(for further references see the PDB file header)

Molecule 1 - GLUCOSE-6-PHOSPHATE 1-DEHYDROGENASE
	Chains	:	A, B
	EC Number	:	1.1.1.49
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Plasmid	:	PTRC99A/DG6PD
	Expression System Strain	:	DF213
	Expression System Taxid	:	562
	Expression System Vector	:	PTRC99A
	Mutation	:	YES
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Other Details	:	THE 25 N-TERMINAL RESIDUES HAVE BEEN REMOVED AND THE FIRST RESIDUE IS VALINE, NOT HISTIDINE
	Synonym	:	G6PD

		1	2
Asymmetric Unit	:	A	B
Biological Unit 1 (2x)	:	A	B

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (2, 8)

No.	Name	Count	Type	Full Name
1	BG6	2	Ligand/Ion	BETA-D-GLUCOSE-6-PHOSPHATE
2	GOL	6	Ligand/Ion	GLYCEROL

Biological Unit 1 (2, 16)

No.	Name	Count	Type	Full Name
1	BG6	4	Ligand/Ion	BETA-D-GLUCOSE-6-PHOSPHATE
2	GOL	12	Ligand/Ion	GLYCEROL

Asymmetric Unit (8, 8)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	LYS A:171 , HIS A:201 , TYR A:202 , LYS A:205 , GLU A:239 , ASP A:258 , HIS A:263 , LYS A:360 , ARG A:365 , GLN A:395	BINDING SITE FOR RESIDUE BG6 A1510
2	AC2	SOFTWARE	LYS B:171 , HIS B:201 , TYR B:202 , LYS B:205 , GLU B:239 , ASP B:258 , HIS B:263 , LYS B:360 , ARG B:365 , GLN B:395	BINDING SITE FOR RESIDUE BG6 B1508
3	AC3	SOFTWARE	SER A:296 , GLU A:297 , VAL A:298 , GLN A:299 , ASN A:302 , VAL A:341 , TYR A:343	BINDING SITE FOR RESIDUE GOL A1506
4	AC4	SOFTWARE	ALA A:300 , VAL A:303 , LEU A:305 , GLN A:471 , PRO A:477	BINDING SITE FOR RESIDUE GOL A1507
5	AC5	SOFTWARE	GLU A:347 , ARG B:215 , PHE B:216 , PHE B:221 , TRP B:225	BINDING SITE FOR RESIDUE GOL A1508
6	AC6	SOFTWARE	ARG A:215 , PHE A:216 , GLY A:222 , TRP A:225 , ARG A:348 , GLU B:347	BINDING SITE FOR RESIDUE GOL A1509
7	AC7	SOFTWARE	TRP B:54 , ARG B:57 , LYS B:89 , LYS B:432 , GLU B:438	BINDING SITE FOR RESIDUE GOL B1506
8	AC8	SOFTWARE	GLY B:163 , TRP B:164 , ARG B:192 , GLN B:195	BINDING SITE FOR RESIDUE GOL B1507

(no "SS Bond" information available for 2BHL)

Asymmetric Unit

No.	Residues
1	Lys A:171	-	Pro A:172
2	Gln A:395	-	Pro A:396
3	Lys B:171	-	Pro B:172
4	Gln B:395	-	Pro B:396

Asymmetric Unit (65, 130)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_002451	H	32	R	G6PD_HUMAN	Disease (NSHA)	137852340	A/B	H	32	R
02	UniProt	VAR_002453	A	44	G	G6PD_HUMAN	Disease (NSHA)	78478128	A/B	A	44	G
03	UniProt	VAR_002454	I	48	T	G6PD_HUMAN	Disease (NSHA)	76645461	A/B	I	48	T
04	UniProt	VAR_002455	D	58	N	G6PD_HUMAN	Disease (NSHA)	137852315	A/B	D	58	N
05	UniProt	VAR_002456	V	68	M	G6PD_HUMAN	Disease (NSHA)	1050828	A/B	V	68	M
06	UniProt	VAR_002457	Y	70	H	G6PD_HUMAN	Disease (NSHA)	137852349	A/B	Y	70	H
07	UniProt	VAR_002458	L	75	P	G6PD_HUMAN	Disease (NSHA)	---	A/B	L	75	P
08	UniProt	VAR_002460	R	81	C	G6PD_HUMAN	Disease (NSHA)	138687036	A/B	R	81	C
09	UniProt	VAR_002459	R	81	H	G6PD_HUMAN	Disease (NSHA)	782308266	A/B	R	81	H
10	UniProt	VAR_002461	S	106	C	G6PD_HUMAN	Disease (NSHA)	267606835	A/B	S	106	C
11	UniProt	VAR_002462	N	126	D	G6PD_HUMAN	Polymorphism	1050829	A/B	N	126	D
12	UniProt	VAR_002463	L	128	P	G6PD_HUMAN	Disease (NSHA)	78365220	A/B	L	128	P
13	UniProt	VAR_002464	G	131	V	G6PD_HUMAN	Polymorphism	137852341	A/B	G	131	V
14	UniProt	VAR_002465	E	156	K	G6PD_HUMAN	Disease (NSHA)	137852313	A/B	E	156	K
15	UniProt	VAR_002467	G	163	D	G6PD_HUMAN	Disease (NSHA)	---	A/B	G	163	D
16	UniProt	VAR_002466	G	163	S	G6PD_HUMAN	Disease (NSHA)	137852314	A/B	G	163	S
17	UniProt	VAR_002468	N	165	D	G6PD_HUMAN	Disease (NSHA)	137852331	A/B	N	165	D
18	UniProt	VAR_002469	R	166	H	G6PD_HUMAN	Disease (NSHA)	---	A/B	R	166	H
19	UniProt	VAR_002470	D	176	G	G6PD_HUMAN	Disease (NSHA)	---	A/B	D	176	G
20	UniProt	VAR_002471	D	181	V	G6PD_HUMAN	Disease (NSHA)	5030872	A/B	D	181	V
21	UniProt	VAR_002472	R	182	W	G6PD_HUMAN	Disease (NSHA)	267606836	A/B	R	182	W
22	UniProt	VAR_002473	S	188	F	G6PD_HUMAN	Disease (NSHA)	5030868	A/B	S	188	F
23	UniProt	VAR_002474	R	198	C	G6PD_HUMAN	Disease (NSHA)	137852330	A/B	R	198	C
24	UniProt	VAR_002475	R	198	P	G6PD_HUMAN	Disease (NSHA)	137852332	A/B	R	198	P
25	UniProt	VAR_075555	R	198	S	G6PD_HUMAN	Disease (NSHA)	---	A/B	R	198	S
26	UniProt	VAR_002476	M	212	V	G6PD_HUMAN	Disease (NSHA)	782754619	A/B	M	212	V
27	UniProt	VAR_002477	V	213	L	G6PD_HUMAN	Disease (NSHA)	137852326	A/B	V	213	L
28	UniProt	VAR_002478	F	216	L	G6PD_HUMAN	Disease (NSHA)	137852319	A/B	F	216	L
29	UniProt	VAR_002480	R	227	L	G6PD_HUMAN	Disease (NSHA)	137852328	A/B	R	227	L
30	UniProt	VAR_002479	R	227	Q	G6PD_HUMAN	Disease (NSHA)	137852328	A/B	R	227	Q
31	UniProt	VAR_002482	R	257	G	G6PD_HUMAN	Disease (NSHA)	---	A/B	R	257	G
32	UniProt	VAR_002483	E	274	K	G6PD_HUMAN	Disease (NSHA)	---	A/B	E	274	K
33	UniProt	VAR_002484	S	278	F	G6PD_HUMAN	Disease (NSHA)	---	A/B	S	278	F
34	UniProt	VAR_002485	T	279	S	G6PD_HUMAN	Disease (NSHA)	---	A/B	T	279	S
35	UniProt	VAR_002486	D	282	H	G6PD_HUMAN	Disease (NSHA)	137852318	A/B	D	282	H
36	UniProt	VAR_002487	R	285	H	G6PD_HUMAN	Disease (NSHA)	74575103	A/B	R	285	H
37	UniProt	VAR_002488	V	291	M	G6PD_HUMAN	Disease (NSHA)	137852327	A/B	V	291	M
38	UniProt	VAR_002489	E	317	K	G6PD_HUMAN	Disease (NSHA)	137852339	A/B	E	317	K
39	UniProt	VAR_020535	Y	322	H	G6PD_HUMAN	Polymorphism	137852347	A/B	Y	322	H
40	UniProt	VAR_002490	L	323	P	G6PD_HUMAN	Disease (NSHA)	76723693	A/B	L	323	P
41	UniProt	VAR_002491	A	335	T	G6PD_HUMAN	Disease (NSHA)	5030869	A/B	A	335	T
42	UniProt	VAR_002492	L	342	F	G6PD_HUMAN	Polymorphism	137852342	A/B	L	342	F
43	UniProt	VAR_002493	P	353	S	G6PD_HUMAN	Disease (NSHA)	137852333	A/B	P	353	S
44	UniProt	VAR_002494	N	363	K	G6PD_HUMAN	Disease (NSHA)	137852329	A/B	N	363	K
45	UniProt	VAR_002495	C	385	R	G6PD_HUMAN	Disease (NSHA)	137852322	A/B	C	385	R
46	UniProt	VAR_002496	K	386	E	G6PD_HUMAN	Disease (NSHA)	137852320	A/B	K	386	E
47	UniProt	VAR_002498	R	387	C	G6PD_HUMAN	Disease (NSHA)	137852334	A/B	R	387	C
48	UniProt	VAR_002497	R	387	H	G6PD_HUMAN	Disease (NSHA)	137852321	A/B	R	387	H
49	UniProt	VAR_002499	R	393	H	G6PD_HUMAN	Disease (NSHA)	137852316	A/B	R	393	H
50	UniProt	VAR_002500	V	394	L	G6PD_HUMAN	Disease (NSHA)	137852335	A/B	V	394	L
51	UniProt	VAR_002501	P	396	L	G6PD_HUMAN	Disease (NSHA)	---	A/B	P	396	L
52	UniProt	VAR_002502	E	398	K	G6PD_HUMAN	Disease (NSHA)	137852325	A/B	E	398	K
53	UniProt	VAR_002503	G	410	C	G6PD_HUMAN	Disease (NSHA)	137852323	A/B	G	410	C
54	UniProt	VAR_002504	G	410	D	G6PD_HUMAN	Disease (NSHA)	137852336	A/B	G	410	D
55	UniProt	VAR_002505	E	416	K	G6PD_HUMAN	Disease (NSHA)	---	A/B	E	416	K
56	UniProt	VAR_002506	R	439	P	G6PD_HUMAN	Disease (NSHA)	137852337	A/B	R	439	P
57	UniProt	VAR_002507	L	440	F	G6PD_HUMAN	Disease (NSHA)	---	A/B	L	440	F
58	UniProt	VAR_002508	G	447	R	G6PD_HUMAN	Disease (NSHA)	137852317	A/B	G	447	R
59	UniProt	VAR_002509	Q	449	H	G6PD_HUMAN	Disease (NSHA)	---	A/B	Q	449	H
60	UniProt	VAR_002510	R	454	C	G6PD_HUMAN	Disease (NSHA)	398123546	A/B	R	454	C
61	UniProt	VAR_002511	R	454	H	G6PD_HUMAN	Disease (NSHA)	137852324	A/B	R	454	H
62	UniProt	VAR_002512	R	459	L	G6PD_HUMAN	Disease (NSHA)	72554665	A/B	R	459	L
63	UniProt	VAR_002513	R	459	P	G6PD_HUMAN	Disease (NSHA)	72554665	A/B	R	459	P
64	UniProt	VAR_002514	R	463	H	G6PD_HUMAN	Disease (NSHA)	72554664	A/B	R	463	H
65	UniProt	VAR_002515	G	488	V	G6PD_HUMAN	Disease (NSHA)	---	A/B	G	488	V

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (65, 260)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_002451	H	32	R	G6PD_HUMAN	Disease (NSHA)	137852340	A/B	H	32	R
02	UniProt	VAR_002453	A	44	G	G6PD_HUMAN	Disease (NSHA)	78478128	A/B	A	44	G
03	UniProt	VAR_002454	I	48	T	G6PD_HUMAN	Disease (NSHA)	76645461	A/B	I	48	T
04	UniProt	VAR_002455	D	58	N	G6PD_HUMAN	Disease (NSHA)	137852315	A/B	D	58	N
05	UniProt	VAR_002456	V	68	M	G6PD_HUMAN	Disease (NSHA)	1050828	A/B	V	68	M
06	UniProt	VAR_002457	Y	70	H	G6PD_HUMAN	Disease (NSHA)	137852349	A/B	Y	70	H
07	UniProt	VAR_002458	L	75	P	G6PD_HUMAN	Disease (NSHA)	---	A/B	L	75	P
08	UniProt	VAR_002460	R	81	C	G6PD_HUMAN	Disease (NSHA)	138687036	A/B	R	81	C
09	UniProt	VAR_002459	R	81	H	G6PD_HUMAN	Disease (NSHA)	782308266	A/B	R	81	H
10	UniProt	VAR_002461	S	106	C	G6PD_HUMAN	Disease (NSHA)	267606835	A/B	S	106	C
11	UniProt	VAR_002462	N	126	D	G6PD_HUMAN	Polymorphism	1050829	A/B	N	126	D
12	UniProt	VAR_002463	L	128	P	G6PD_HUMAN	Disease (NSHA)	78365220	A/B	L	128	P
13	UniProt	VAR_002464	G	131	V	G6PD_HUMAN	Polymorphism	137852341	A/B	G	131	V
14	UniProt	VAR_002465	E	156	K	G6PD_HUMAN	Disease (NSHA)	137852313	A/B	E	156	K
15	UniProt	VAR_002467	G	163	D	G6PD_HUMAN	Disease (NSHA)	---	A/B	G	163	D
16	UniProt	VAR_002466	G	163	S	G6PD_HUMAN	Disease (NSHA)	137852314	A/B	G	163	S
17	UniProt	VAR_002468	N	165	D	G6PD_HUMAN	Disease (NSHA)	137852331	A/B	N	165	D
18	UniProt	VAR_002469	R	166	H	G6PD_HUMAN	Disease (NSHA)	---	A/B	R	166	H
19	UniProt	VAR_002470	D	176	G	G6PD_HUMAN	Disease (NSHA)	---	A/B	D	176	G
20	UniProt	VAR_002471	D	181	V	G6PD_HUMAN	Disease (NSHA)	5030872	A/B	D	181	V
21	UniProt	VAR_002472	R	182	W	G6PD_HUMAN	Disease (NSHA)	267606836	A/B	R	182	W
22	UniProt	VAR_002473	S	188	F	G6PD_HUMAN	Disease (NSHA)	5030868	A/B	S	188	F
23	UniProt	VAR_002474	R	198	C	G6PD_HUMAN	Disease (NSHA)	137852330	A/B	R	198	C
24	UniProt	VAR_002475	R	198	P	G6PD_HUMAN	Disease (NSHA)	137852332	A/B	R	198	P
25	UniProt	VAR_075555	R	198	S	G6PD_HUMAN	Disease (NSHA)	---	A/B	R	198	S
26	UniProt	VAR_002476	M	212	V	G6PD_HUMAN	Disease (NSHA)	782754619	A/B	M	212	V
27	UniProt	VAR_002477	V	213	L	G6PD_HUMAN	Disease (NSHA)	137852326	A/B	V	213	L
28	UniProt	VAR_002478	F	216	L	G6PD_HUMAN	Disease (NSHA)	137852319	A/B	F	216	L
29	UniProt	VAR_002480	R	227	L	G6PD_HUMAN	Disease (NSHA)	137852328	A/B	R	227	L
30	UniProt	VAR_002479	R	227	Q	G6PD_HUMAN	Disease (NSHA)	137852328	A/B	R	227	Q
31	UniProt	VAR_002482	R	257	G	G6PD_HUMAN	Disease (NSHA)	---	A/B	R	257	G
32	UniProt	VAR_002483	E	274	K	G6PD_HUMAN	Disease (NSHA)	---	A/B	E	274	K
33	UniProt	VAR_002484	S	278	F	G6PD_HUMAN	Disease (NSHA)	---	A/B	S	278	F
34	UniProt	VAR_002485	T	279	S	G6PD_HUMAN	Disease (NSHA)	---	A/B	T	279	S
35	UniProt	VAR_002486	D	282	H	G6PD_HUMAN	Disease (NSHA)	137852318	A/B	D	282	H
36	UniProt	VAR_002487	R	285	H	G6PD_HUMAN	Disease (NSHA)	74575103	A/B	R	285	H
37	UniProt	VAR_002488	V	291	M	G6PD_HUMAN	Disease (NSHA)	137852327	A/B	V	291	M
38	UniProt	VAR_002489	E	317	K	G6PD_HUMAN	Disease (NSHA)	137852339	A/B	E	317	K
39	UniProt	VAR_020535	Y	322	H	G6PD_HUMAN	Polymorphism	137852347	A/B	Y	322	H
40	UniProt	VAR_002490	L	323	P	G6PD_HUMAN	Disease (NSHA)	76723693	A/B	L	323	P
41	UniProt	VAR_002491	A	335	T	G6PD_HUMAN	Disease (NSHA)	5030869	A/B	A	335	T
42	UniProt	VAR_002492	L	342	F	G6PD_HUMAN	Polymorphism	137852342	A/B	L	342	F
43	UniProt	VAR_002493	P	353	S	G6PD_HUMAN	Disease (NSHA)	137852333	A/B	P	353	S
44	UniProt	VAR_002494	N	363	K	G6PD_HUMAN	Disease (NSHA)	137852329	A/B	N	363	K
45	UniProt	VAR_002495	C	385	R	G6PD_HUMAN	Disease (NSHA)	137852322	A/B	C	385	R
46	UniProt	VAR_002496	K	386	E	G6PD_HUMAN	Disease (NSHA)	137852320	A/B	K	386	E
47	UniProt	VAR_002498	R	387	C	G6PD_HUMAN	Disease (NSHA)	137852334	A/B	R	387	C
48	UniProt	VAR_002497	R	387	H	G6PD_HUMAN	Disease (NSHA)	137852321	A/B	R	387	H
49	UniProt	VAR_002499	R	393	H	G6PD_HUMAN	Disease (NSHA)	137852316	A/B	R	393	H
50	UniProt	VAR_002500	V	394	L	G6PD_HUMAN	Disease (NSHA)	137852335	A/B	V	394	L
51	UniProt	VAR_002501	P	396	L	G6PD_HUMAN	Disease (NSHA)	---	A/B	P	396	L
52	UniProt	VAR_002502	E	398	K	G6PD_HUMAN	Disease (NSHA)	137852325	A/B	E	398	K
53	UniProt	VAR_002503	G	410	C	G6PD_HUMAN	Disease (NSHA)	137852323	A/B	G	410	C
54	UniProt	VAR_002504	G	410	D	G6PD_HUMAN	Disease (NSHA)	137852336	A/B	G	410	D
55	UniProt	VAR_002505	E	416	K	G6PD_HUMAN	Disease (NSHA)	---	A/B	E	416	K
56	UniProt	VAR_002506	R	439	P	G6PD_HUMAN	Disease (NSHA)	137852337	A/B	R	439	P
57	UniProt	VAR_002507	L	440	F	G6PD_HUMAN	Disease (NSHA)	---	A/B	L	440	F
58	UniProt	VAR_002508	G	447	R	G6PD_HUMAN	Disease (NSHA)	137852317	A/B	G	447	R
59	UniProt	VAR_002509	Q	449	H	G6PD_HUMAN	Disease (NSHA)	---	A/B	Q	449	H
60	UniProt	VAR_002510	R	454	C	G6PD_HUMAN	Disease (NSHA)	398123546	A/B	R	454	C
61	UniProt	VAR_002511	R	454	H	G6PD_HUMAN	Disease (NSHA)	137852324	A/B	R	454	H
62	UniProt	VAR_002512	R	459	L	G6PD_HUMAN	Disease (NSHA)	72554665	A/B	R	459	L
63	UniProt	VAR_002513	R	459	P	G6PD_HUMAN	Disease (NSHA)	72554665	A/B	R	459	P
64	UniProt	VAR_002514	R	463	H	G6PD_HUMAN	Disease (NSHA)	72554664	A/B	R	463	H
65	UniProt	VAR_002515	G	488	V	G6PD_HUMAN	Disease (NSHA)	---	A/B	G	488	V

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (1, 2)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	G6P_DEHYDROGENASE	PS00069	Glucose-6-phosphate dehydrogenase active site.	G6PD_HUMAN	200-206	2	A:200-206 B:200-206

Biological Unit 1 (1, 4)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	G6P_DEHYDROGENASE	PS00069	Glucose-6-phosphate dehydrogenase active site.	G6PD_HUMAN	200-206	4	A:200-206 B:200-206

Asymmetric Unit (12, 24)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000393564	1a	ENSE00001450454	X:153775787-153775683	105	G6PD_HUMAN	-	0	0	-	-
1.3a	ENST00000393564	3a	ENSE00001629012	X:153774378-153774251	128	G6PD_HUMAN	1-40	40	2	A:27-40 B:27-40	14 14
1.4	ENST00000393564	4	ENSE00001050596	X:153764393-153764356	38	G6PD_HUMAN	41-53	13	2	A:41-53 B:41-53	13 13
1.5a	ENST00000393564	5a	ENSE00001200322	X:153764260-153764152	109	G6PD_HUMAN	53-89	37	2	A:53-89 B:53-89	37 37
1.6a	ENST00000393564	6a	ENSE00001050603	X:153763600-153763383	218	G6PD_HUMAN	90-162	73	2	A:90-162 B:90-162	73 73
1.7b	ENST00000393564	7b	ENSE00001050595	X:153762711-153762553	159	G6PD_HUMAN	162-215	54	2	A:162-215 B:162-215	54 54
1.8c	ENST00000393564	8c	ENSE00001050598	X:153762375-153762250	126	G6PD_HUMAN	215-257	43	2	A:215-257 B:215-257	43 43
1.9b	ENST00000393564	9b	ENSE00001050601	X:153761884-153761791	94	G6PD_HUMAN	257-288	32	2	A:257-288 B:257-288	32 32
1.10c	ENST00000393564	10c	ENSE00001050608	X:153761343-153761157	187	G6PD_HUMAN	289-351	63	2	A:289-351 B:289-351	63 63
1.10e	ENST00000393564	10e	ENSE00001050602	X:153761017-153760782	236	G6PD_HUMAN	351-429	79	2	A:351-429 B:351-429	79 79
1.11	ENST00000393564	11	ENSE00001050597	X:153760677-153760601	77	G6PD_HUMAN	430-455	26	2	A:430-455 B:430-455	26 26
1.12b	ENST00000393564	12b	ENSE00001050600	X:153760495-153760403	93	G6PD_HUMAN	455-486	32	2	A:455-486 B:455-486	32 32
1.12d	ENST00000393564	12d	ENSE00001515849	X:153760305-153760215	91	G6PD_HUMAN	486-515	30	2	A:486-505 B:486-505	20 20

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:479
 aligned with G6PD_HUMAN | P11413 from UniProtKB/Swiss-Prot  Length:515

    Alignment length:479
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       466       476       486       496         
           G6PD_HUMAN    27 HQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEG 505
               SCOP domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 2bhlA01 A:27-199,A:433-453 NAD(P)-binding Rossmann-like Domain                                                                                                               2bhlA02 A:200-432,A:454-505 Dihydrodipicolinate Reductase; domain 2                                                                                                                                                                      2bhlA01              2bhlA02 A:200-432,A:454-505                          CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeeeee....hhhhhhhhhhhhhhhh.......eeeeeee.....hhhhhhhh............hhhhhh..eeeee.....hhhhhhhhhhhhh.......eeeeee......hhhhhhhhhh........eeeee.......hhhhhhhhhhhhhh.....eee..hhhh.hhhhhhhhhhh.............eeeeeeeeee..........hhhh.hhhhh...hhhhhhhhhh........hhhhhhhhhhhh..........eeeeeee.......hhh.................eeeeeee.........eeeeeeee.....eeeeeeee...............eeeeeee...eeeeeeeee.......eeeeeeeeehhhh........hhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhh....eeee......hhhhhhhhhh...... Sec.struct. author
             SAPs(SNPs) (1) -----R-----------G---T---------N---------M-H----P-----C------------------------C-------------------D-P--V------------------------K------D-DH---------G----VW-----F---------C-------------VL--L----------L-----------------------------G----------------K---FS--H--H-----M-------------------------K----HP-----------T------F----------S---------K---------------------REC-----HL-L-K-----------C-----K----------------------PF------R-H----C----L---H------------------------V----------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------H---------------------------------------------------------------------------------S----------------------------------P----------------------------Q---------------------------------------------------------------------------------------------------------------------------------------------------------------H----------------------D-------------------------------------------H----P---------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------S------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------G6P_DEH----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.3a     Exon 1.4     ------------------------------------Exon 1.6a  PDB: A:90-162 UniProt: 90-162                                 ----------------------------------------------------Exon 1.8c  PDB: A:215-257 UniProt: 215-257 -------------------------------Exon 1.10c  PDB: A:289-351 UniProt: 289-351                    ------------------------------------------------------------------------------Exon 1.11  PDB: A:430-455 ------------------------------Exon 1.12d           Transcript 1 (1)
           Transcript 1 (2) --------------------------Exon 1.5a  PDB: A:53-89              ------------------------------------------------------------------------Exon 1.7b  PDB: A:162-215 UniProt: 162-215            -----------------------------------------Exon 1.9b  PDB: A:257-288       --------------------------------------------------------------Exon 1.10e  PDB: A:351-429 UniProt: 351-429                                    -------------------------Exon 1.12b  PDB: A:455-486      ------------------- Transcript 1 (2)
                 2bhl A  27 VQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEG 505
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       466       476       486       496

Chain B from PDB  Type:PROTEIN  Length:479
 aligned with G6PD_HUMAN | P11413 from UniProtKB/Swiss-Prot  Length:515

    Alignment length:479
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       466       476       486       496         
           G6PD_HUMAN    27 HQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEG 505
               SCOP domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 2bhlB01 B:27-199,B:433-453 NAD(P)-binding Rossmann-like Domain                                                                                                               2bhlB02 B:200-432,B:454-505 Dihydrodipicolinate Reductase; domain 2                                                                                                                                                                      2bhlB01              2bhlB02 B:200-432,B:454-505                          CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeeeee....hhhhhhhhhhhhhhhh.......eeeeeee.....hhhhhhhh..........hhhhhhhhh.eeeee.....hhhhhhhhhhhhh.......eeeeee...hhhhhhhhhhhhh........eeeee.......hhhhhhhhhhhhhh.....eee..hhhh.hhhhhhhhhhh.............eeeeeeeee........hhhhh....hhhh...hhhhhhhhhh........hhhhhhhhhhhh..........eeeeeee......hhhh.................eeeeeee.........eeeeeee......eeeeeeee...............eeeeeee...eeeeeeeee.......eeeeeeeeehhhh........hhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhh.....eeee......hhhhhhhhhh...... Sec.struct. author
             SAPs(SNPs) (1) -----R-----------G---T---------N---------M-H----P-----C------------------------C-------------------D-P--V------------------------K------D-DH---------G----VW-----F---------C-------------VL--L----------L-----------------------------G----------------K---FS--H--H-----M-------------------------K----HP-----------T------F----------S---------K---------------------REC-----HL-L-K-----------C-----K----------------------PF------R-H----C----L---H------------------------V----------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------H---------------------------------------------------------------------------------S----------------------------------P----------------------------Q---------------------------------------------------------------------------------------------------------------------------------------------------------------H----------------------D-------------------------------------------H----P---------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------S------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------G6P_DEH----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.3a     Exon 1.4     ------------------------------------Exon 1.6a  PDB: B:90-162 UniProt: 90-162                                 ----------------------------------------------------Exon 1.8c  PDB: B:215-257 UniProt: 215-257 -------------------------------Exon 1.10c  PDB: B:289-351 UniProt: 289-351                    ------------------------------------------------------------------------------Exon 1.11  PDB: B:430-455 ------------------------------Exon 1.12d           Transcript 1 (1)
           Transcript 1 (2) --------------------------Exon 1.5a  PDB: B:53-89              ------------------------------------------------------------------------Exon 1.7b  PDB: B:162-215 UniProt: 162-215            -----------------------------------------Exon 1.9b  PDB: B:257-288       --------------------------------------------------------------Exon 1.10e  PDB: B:351-429 UniProt: 351-429                                    -------------------------Exon 1.12b  PDB: B:455-486      ------------------- Transcript 1 (2)
                 2bhl B  27 VQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEG 505
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       466       476       486       496

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "SCOP Domain" information available for 2BHL)

Asymmetric Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Alpha Beta (26913)

Architecture: 2-Layer Sandwich (8480)

Topology: Dihydrodipicolinate Reductase; domain 2 (182)

Homologous Superfamily: Dihydrodipicolinate Reductase; domain 2 (178)

Human (Homo sapiens) (8)

1a	2bhlA02	A:200-432,A:454-505
1b	2bhlB02	B:200-432,B:454-505

Architecture: 3-Layer(aba) Sandwich (12045)

Topology: Rossmann fold (7312)

Homologous Superfamily: NAD(P)-binding Rossmann-like Domain (1244)

Human (Homo sapiens) (188)

2a	2bhlA01	A:27-199,A:433-453
2b	2bhlB01	B:27-199,B:433-453

(no "Pfam Domain" information available for 2BHL)

Asymmetric Unit(hide GO term definitions)

Chain A,B (G6PD_HUMAN | P11413)

molecular function
	GO:0050661	NADP binding	Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.
	GO:0030246	carbohydrate binding	Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
	GO:0005536	glucose binding	Interacting selectively and non-covalently with the D- or L-enantiomer of glucose.
	GO:0004345	glucose-6-phosphate dehydrogenase activity	Catalysis of the reaction: D-glucose 6-phosphate + NADP+ = D-glucono-1,5-lactone 6-phosphate + NADPH + H+.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
	GO:0016491	oxidoreductase activity	Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0042803	protein homodimerization activity	Interacting selectively and non-covalently with an identical protein to form a homodimer.
biological process
	GO:0006739	NADP metabolic process	The chemical reactions and pathways involving nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; metabolism may be of either the oxidized form, NADP, or the reduced form, NADPH.
	GO:0006740	NADPH regeneration	A metabolic process that generates a pool of NADPH by the reduction of NADP+.
	GO:0005975	carbohydrate metabolic process	The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule.
	GO:0034599	cellular response to oxidative stress	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
	GO:0006695	cholesterol biosynthetic process	The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
	GO:0043249	erythrocyte maturation	A developmental process, independent of morphogenetic (shape) change, that is required for an erythrocyte to attain its fully functional state.
	GO:0051156	glucose 6-phosphate metabolic process	The chemical reactions and pathways involving glucose 6-phosphate, a monophosphorylated derivative of glucose with the phosphate group attached to C-6.
	GO:0006006	glucose metabolic process	The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
	GO:0006749	glutathione metabolic process	The chemical reactions and pathways involving glutathione, the tripeptide glutamylcysteinylglycine, which acts as a coenzyme for some enzymes and as an antioxidant in the protection of sulfhydryl groups in enzymes and other proteins; it has a specific role in the reduction of hydrogen peroxide (H2O2) and oxidized ascorbate, and it participates in the gamma-glutamyl cycle.
	GO:0006629	lipid metabolic process	The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
	GO:0010734	negative regulation of protein glutathionylation	Any process that decreases the rate, frequency, or extent of protein glutathionylation. Protein glutathionylation is the protein modification process in which a glutathione molecule is added to a protein amino acid through a disulfide linkage.
	GO:0055114	oxidation-reduction process	A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
	GO:0019322	pentose biosynthetic process	The chemical reactions and pathways resulting in the formation of a pentose, any monosaccharide with a chain of five carbon atoms in the molecule.
	GO:0006098	pentose-phosphate shunt	The glucose-6-phosphate catabolic process in which, coupled to NADPH synthesis, glucose-6-P is oxidized with the formation of carbon dioxide (CO2) and ribulose 5-phosphate; ribulose 5-P then enters a series of reactions interconverting sugar phosphates. The pentose phosphate pathway is a major source of reducing equivalents for biosynthesis reactions and is also important for the conversion of hexoses to pentoses.
	GO:0009051	pentose-phosphate shunt, oxidative branch	The branch of the pentose-phosphate shunt which involves the oxidation of glucose 6-P and produces ribulose 5-P, reduced NADP+ and carbon dioxide (CO2).
	GO:0043523	regulation of neuron apoptotic process	Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
	GO:0045471	response to ethanol	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
	GO:0032094	response to food	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat.
	GO:0014070	response to organic cyclic compound	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
	GO:0046390	ribose phosphate biosynthetic process	The chemical reactions and pathways resulting in the formation of ribose phosphate, any phosphorylated ribose sugar.
	GO:0021762	substantia nigra development	The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis).
cellular component
	GO:0005813	centrosome	A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0009898	cytoplasmic side of plasma membrane	The leaflet the plasma membrane that faces the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0043231	intracellular membrane-bounded organelle	Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005815	microtubule organizing center	An intracellular structure that can catalyze gamma-tubulin-dependent microtubule nucleation and that can anchor microtubules by interacting with their minus ends, plus ends or sides.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		BG6	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GOL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Gln A:395 - Pro A:396	[ RasMol ]
		Gln B:395 - Pro B:396	[ RasMol ]
		Lys A:171 - Pro A:172	[ RasMol ]
		Lys B:171 - Pro B:172	[ RasMol ]

Biological Unit
	Complete Structure
		Biological Unit 1	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	2bhl
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	G6PD_HUMAN \| P11413
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	1.1.1.49
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	300908
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	G6PD_HUMAN \| P11413
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

UniProtKB/Swiss-Prot
	G6PD_HUMAN \| P11413	:	1qki 2bh9 5ukw

1qki	X-RAY STRUCTURE OF HUMAN GLUCOSE 6- PHOSPHATE DEHYDROGENASE (VARIANT CANTON R459L) COMPLEXED WITH STRUCTURAL NADP+
2bh9	X-RAY STRUCTURE OF A DELETION VARIANT OF HUMAN GLUCOSE 6-PHOSPHATE DEHYDROGENASE COMPLEXED WITH STRUCTURAL AND COENZYME NADP

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 8)

Sites (8, 8)

SS Bonds (0, 0)

Cis Peptide Bonds (4, 4)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (65, 130)

PROSITE Motifs (1, 2)

Exons (12, 24)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (2, 4)

Pfam Domains (0, 0)

Gene Ontology (38, 38)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File